VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 8, 2026
Stock Comparison
Amgen Inc. vs Alimentation Couche-Tard Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Amgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Alimentation Couche-Tard Inc.
ATD · Toronto Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Alimentation Couche-Tard Inc.'s moat claims, evidence, and risks.
View ATD analysisComparison highlights
- Moat score gap: Amgen Inc. leads (70 / 100 vs 58 / 100 for Alimentation Couche-Tard Inc.).
- Segment focus: Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines); Alimentation Couche-Tard Inc. has 3 segments (74% in Road transportation fuel (retail fuel and related mobility services)).
- Primary market structure: Competitive vs Competitive. Pricing power: Moderate vs Weak.
- Moat breadth: Amgen Inc. has 5 moat types across 3 domains; Alimentation Couche-Tard Inc. has 5 across 2.
Primary market context
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Alimentation Couche-Tard Inc.
Road transportation fuel (retail fuel and related mobility services)
Road transportation fuel retail (gasoline/diesel) at convenience sites; includes unmanned/automated fuel stations
North America and Europe (plus select other regions via the network)
Consumers and small fleets
Fuel retailer and site operator
74%
Side-by-side metrics
Moat coverage
Shared moat types
Amgen Inc. strengths
Alimentation Couche-Tard Inc. strengths
Segment mix
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Alimentation Couche-Tard Inc. segments
Full profile >Merchandise and services (in-store convenience retail)
Competitive
Road transportation fuel (retail fuel and related mobility services)
Competitive
Other revenues (ancillary energy and other income streams)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.